Related Experiment Video
Updated: Nov 3, 2025
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
Jun Ma1, Clark C Chen1, Ming Li1
1Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA.
Abstract:
The complex interaction between glioblastoma and its microenvironment has been recognized for decades. Among various immune profiles, the major population is tumor-associated macrophage, with microglia as its localized homolog. The present definition of such myeloid cells is based on a series of cell markers. These good sentinel cells experience significant changes, facilitating glioblastoma development and protecting it from therapeutic treatments. Huge, complicated mechanisms are involved during the overall processes. A lot of effort has been dedicated to crack the mysterious codes in macrophage/microglia recruiting, activating, reprogramming, and functioning. We have made our path. With more and more key factors identified, a lot of new therapeutic methods could be explored to break the ominous loop, to enhance tumor sensitivity to treatments, and to improve the prognosis of glioblastoma patients. However, it might be a synergistic system rather than a series of clear, stepwise events. There are still significant challenges before the light of truth can shine onto the field. Here, we summarize recent advances in this field, reviewing the path we have been on and where we are now.
Insights
Tumor-associated macrophages and microglia play key roles in glioblastoma development and treatment resistance. Understanding their complex functions offers new therapeutic avenues for improving patient outcomes.
Area of Science:
- Neuro-oncology
- Immunology
- Cell Biology
Background:
- Glioblastoma's complex interaction with its microenvironment is well-established.
- Tumor-associated macrophages (TAMs) and their counterparts in the brain, microglia, are major immune components.
- These myeloid cells undergo significant alterations that promote tumor growth and therapeutic resistance.
Purpose of the Study:
- To review recent advances in understanding myeloid cell roles in glioblastoma.
- To explore the mechanisms of myeloid cell recruitment, activation, reprogramming, and function.
- To identify challenges and future directions in targeting these cells for glioblastoma therapy.
Main Methods:
- Review of current literature on glioblastoma immunology and myeloid cell biology.
- Analysis of key factors influencing macrophage and microglia behavior in the tumor microenvironment.
- Synthesis of findings to highlight therapeutic opportunities.
Main Results:
- Identification of critical mechanisms governing myeloid cell dynamics in glioblastoma.
- Recognition of the complex, potentially synergistic, nature of these interactions.
- Emerging therapeutic strategies targeting myeloid cells are being explored.
Conclusions:
- Targeting tumor-associated macrophages and microglia presents a promising strategy for glioblastoma treatment.
- Further research is needed to fully elucidate the intricate mechanisms involved.
- Overcoming current challenges may lead to improved glioblastoma patient prognosis.
